Welcome to our dedicated page for Apogee Entr SEC filings (Ticker: APOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Apogee Enterprises, Inc. (Nasdaq: APOG) SEC filings page provides access to the company’s regulatory disclosures as a public issuer in the United States. Apogee, a Minnesota corporation headquartered in Minneapolis, files reports with the U.S. Securities and Exchange Commission related to its activities as a provider of architectural building products and services and high-performance coated materials.
Through this page, readers can review current reports on Form 8-K that Apogee files to describe material events. Recent 8-K filings have covered topics such as CEO transitions, CFO changes, appointments of segment presidents, and the release of quarterly financial results. These filings may include details on executive compensation arrangements, separation agreements, offer letters, and other governance-related matters.
In addition to 8-Ks, investors typically look to Apogee’s annual reports on Form 10-K and quarterly reports on Form 10-Q for information about segment performance, non-GAAP measures like adjusted EBITDA and consolidated leverage ratio, and risk factors related to non-residential construction cycles, material costs, tariffs, and project execution. Proxy materials and shareholder meeting results, such as vote outcomes for director elections, advisory votes on executive compensation, and auditor ratification, are also reflected in the company’s filings.
Stock Titan’s platform pairs these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify items such as leadership changes, compensation terms, and significant financial disclosures. Users can track governance developments, monitor how Apogee describes its backlog and non-GAAP metrics, and follow the company’s formal communications with regulators and shareholders, all in one place with real-time updates from the SEC’s EDGAR system.
Alvord Christina M reported acquisition or exercise transactions in this Form 4 filing.
Apogee Enterprises director Christina M. Alvord received a grant of deferred restricted stock units. She was awarded 84 deferred restricted stock units at a reference value of $33.54 per unit, each settling 1-for-1 into common stock. After this award, she holds 10,539 deferred restricted stock units directly. These units were granted under the 2019 Non-Employee Director Stock Plan and will be settled in shares of common stock after she leaves the Board or upon other events specified in the plan, consistent with her prior deferral elections and dividend reinvestment features.
APOGEE ENTERPRISES, INC. director Mark A. Pompa reported routine equity-based compensation changes. He acquired 80 phantom stock units and 199 deferred restricted stock units, both valued at $33.54 per unit, through dividend equivalent reinvestment features of director compensation plans.
Following these awards, Pompa holds 10,075 phantom stock units and 24,840 deferred restricted stock units. Both instruments are designed to be settled 1-for-1 in shares of common stock after his termination from the Board or other plan-specified events, aligning director compensation with shareholder outcomes rather than reflecting open-market trading.
Lilly Elizabeth Murphy reported acquisition or exercise transactions in this Form 4 filing.
Apogee Enterprises director Elizabeth Murphy received a routine equity grant in the form of deferred restricted stock units. She was awarded 55 deferred units tied to Apogee common stock at a reference value of $33.54 per unit, increasing her direct holdings of these units to 6,900.
The units were granted under Apogee’s 2019 Non-Employee Director Stock Plan and include additional allocations from a dividend equivalent reinvestment feature. Each unit is settled 1-for-1 in common shares after she leaves the Board or upon other events specified in the plan, so this filing reflects compensation rather than an open-market share purchase.
Apogee Enterprises’ Chief Executive Officer Donald A. Nolan reported compensation-related grants of derivative awards rather than open-market trades. He acquired 85 phantom stock units and 580 deferred restricted stock units on March 31, 2026 at a reference price of $33.54 per unit.
The phantom and deferred restricted stock units are designed to be settled 1-for-1 in common stock under company plans, generally after the director’s termination from the Board or other plan events. Following these grants, Nolan holds 10,613 phantom stock units and 72,845 deferred restricted stock units directly.
APOGEE ENTERPRISES, INC. director Lloyd Emerson Johnson acquired 153 deferred restricted stock units on March 31, 2026 as a grant under company director stock plans. These units were credited through a dividend equivalent reinvestment feature and are settled 1-for-1 in common stock.
The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. They will be settled in shares of common stock after Johnson’s termination from the Board or upon other events specified in the plans. Following this grant, he holds 19,264 deferred restricted stock units directly.
Apogee Enterprises Inc. — The Vanguard Group filed Amendment No. 18 to its Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Apogee common stock. The amendment notes an internal realignment on January 12, 2026 under SEC Release No. 34-39538 that disaggregated certain Vanguard subsidiaries, and states Vanguard no longer is deemed to beneficially own securities held by those subsidiaries. The filing lists Vanguard's address and was signed by Ashley Grim as Head of Global Fund Administration on March 26, 2026.
Welp Bryan Alan reported acquisition or exercise transactions in this Form 4 filing.
APOGEE ENTERPRISES, INC. reported that VP and General Counsel Bryan Alan Welp received a grant of 1,992 shares of common stock on 2/2/26, valued at $37.66 per share. These shares vest over two years, with one-half vesting on 2/2/27 and the remainder on 2/2/28.
Following this award, Welp directly holds 4,032 common shares. The filing also notes that this total includes shares allocated under the Employee Stock Purchase Plan as of 2/2/26, underscoring that the transaction is part of routine equity compensation rather than an open-market purchase.
APOGEE ENTERPRISES, INC. executive Bryan Alan Welp, the company’s VP and General Counsel, has filed an initial ownership report showing his holdings of common stock. The Form 3 indicates he directly owns 2,026 shares of common stock following the reported date.
According to a footnote, this amount includes shares allocated under the Employee Stock Purchase Plan as of February 2, 2026. The filing records Welp’s existing equity position and does not report any new stock purchases or sales.
Augdahl Mark Richard reported acquisition or exercise transactions in this Form 4 filing.
Apogee Enterprises, Inc. reported that Interim CFO Mark Richard Augdahl received a grant of 18,960 shares of common stock on January 19, 2026 as a stock award, not an open-market purchase. The award was priced at $36.92 per share for reporting purposes.
After this grant, Augdahl directly holds 32,351 common shares. The granted shares are restricted and vest in two equal installments of 50% on January 19, 2027 and January 19, 2028, under the company’s 2019 Stock Incentive Plan.
APOGEE ENTERPRISES, INC. interim CFO Mark Richard Augdahl filed an initial Form 3 reporting beneficial ownership of 13,391 shares of common stock as of January 15, 2026. These holdings include shares allocated under the Employee Stock Purchase Plan and restricted stock granted under the 2019 Stock Incentive Plan, with no specific buy or sell transactions reported.